#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Salivary gland cancer Oesophageal adenocarcinoma Langerhans' cell histiocytosis Synovial sarcoma recurrent Amyloidosis Huntington's disease Myeloid leukaemia Aspergillus infection Adenocarcinoma pancreas Bronchiolitis Neurofibromatosis Infantile apnoea Cardiac amyloidosis Chronic myelomonocytic leukaemia Alveolar rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Diagnostics Rhabdomyosarcoma recurrent – Basic Information Wolfram syndrome Basal cell naevus syndrome – Treatment Metachromatic leukodystrophy Medulloblastoma recurrent – Basic Information Wolfram syndrome – Trials in Disease Fabry’s disease – Life with Disease Lymphangiosarcoma Gaucher’s disease type III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tipiracil Tafasitamab Citalopram Hydrochloride Caba-201 AZD6234 Bevacizumab Osteodex Tacrolimus Monohydrate Dexamethasone Sodium Phosphate Silibinin Hydrocortisone ALN-961583 Isaralgagene Civaparvovec Nepafenac Pd01B ZIMISLECEL Jnj-77242113 Ubiquinol Petrelintide Eprosartan Mesilate More therapies…

    Learn about Your Condition

    Sjogren's syndrome Peripheral artery thrombosis Malignant lymphoid neoplasm Atrial flutter Ventricular tachycardia Critical illness Amyotrophic lateral sclerosis Peripheral spondyloarthritis Bladder cancer stage III Phaeochromocytoma Mixed dementia Pulmonary fibrosis Gout Angiosarcoma Cutaneous sarcoidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Sofiamed OOD

Ulitsa Dimitir Mollov 10, Sofia, 1750, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Bulgaria Italy Poland Spain

  • Study of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Degarelix
    Belgium Bulgaria France Italy Lithuania Poland +1

  • Study Comparing the Effects and Safety of FYB206 and Pembrolizumab with Chemotherapy in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Pembrolizumab
    Bulgaria Poland Romania

  • Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

    Not recruiting

    2 1
    Investigated Drugs:
    • Ab-1002
    Austria Belgium Bulgaria Germany Hungary The Netherlands +3

  • Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • ZELENECTIDE PEVEDOTIN
    • Avelumab
    • Carboplatin
    Austria Belgium Bulgaria Czechia Denmark France +12

  • Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • EGFR gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Amivantamab
    • Carboplatin
    • Lazertinib
    Belgium Bulgaria Czechia Denmark France Germany +6

  • Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Tebipenem Pivoxil Hydrobromide
    • Cilastatin
    • Imipenem Anhydrate
    Bulgaria Croatia Estonia Greece Hungary Latvia +3

  • Long-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!